Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis [PDF]
Melissa Inman+3 more
openalex +1 more source
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort [PDF]
Andrew Mallett+12 more
openalex +1 more source
Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab [PDF]
Zahra Iqbal+5 more
openalex +1 more source
In Reply to ‘Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome’ [PDF]
Gianluigi Ardissino+2 more
openalex +1 more source
Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipient. [PDF]
Laban T+11 more
europepmc +1 more source
Successful use of eculizumab in a patient with post‐transplant thrombotic microangiopathy
Régis Peffault de Latour+6 more
openalex +1 more source
Therapeutic strategies targeting complement in myasthenia gravis patients. [PDF]
Wang Y, Nao J, Duan Y, Li Z, Feng J.
europepmc +1 more source